Columbia Threadneedle’s Corporate Income Fund returned 2.05% in Q2 2025 amid market volatility and tariff shocks. Explore how ...

The most likely range for 3-month bill yields falls to the 1% to 2% range within 30 months, according to this week’s ...

Columbia Threadneedle’s Convertible Securities Fund beat its benchmark in Q2 2025, fueled by tech and crypto-linked ...

XONE offers low-cost, short-duration Treasury exposure, making it attractive for those seeking limited duration risk. See why ...

Suzano maintains a strong cost advantage in pulp production, exporting to stable and growing markets, creating a solid moat ...

Gilead Sciences' valuation exceeds fundamentals, prompting a SELL recommendation. Discover why this $150B biopharma stock may ...

Columbia Threadneedle’s Bond Fund beat its benchmark in Q2 2025 with smart duration and credit picks. See how it navigated ...

Schlumberger is undervalued vs. peers, with ChampionX synergies, solid financials, and segment growth offsetting risks. Find ...

Lyft's domestic partnership and global expansion reflect proper investment decisions by management. Learn why LYFT stock is a ...

Google ( NASDAQ: GOOG) agreed on Monday to pay a fine of A$55 million ($35.8 million) in Australia after the country’s ...

After a strong June, the REIT sector recovery stalled in July as REITs fell to a -6.42% year-to-date return. Read more here.

Definitive Health beats on Q2 revenue and EPS, but weak Life Sciences subscriptions and structural pressures remain. Read why ...